ES2008204A6 - Metodos para producir cuerpos de inclusion polihedrica de composicion mezclada (pib),para coinfectar insectos huespedes y para producir proteinas heterologas en insectos. - Google Patents

Metodos para producir cuerpos de inclusion polihedrica de composicion mezclada (pib),para coinfectar insectos huespedes y para producir proteinas heterologas en insectos.

Info

Publication number
ES2008204A6
ES2008204A6 ES878702586A ES8702586A ES2008204A6 ES 2008204 A6 ES2008204 A6 ES 2008204A6 ES 878702586 A ES878702586 A ES 878702586A ES 8702586 A ES8702586 A ES 8702586A ES 2008204 A6 ES2008204 A6 ES 2008204A6
Authority
ES
Spain
Prior art keywords
pib
baculoviruses
heterologous protein
producing
mixed composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES878702586A
Other languages
English (en)
Inventor
David W Miller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genetics Institute LLC
Original Assignee
Genetics Institute LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genetics Institute LLC filed Critical Genetics Institute LLC
Publication of ES2008204A6 publication Critical patent/ES2008204A6/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/14011—Baculoviridae
    • C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
    • C12N2710/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

METODO PARA PRODUCIR CUERPOS DE INCLUSION POLIHEDRICA DE COMPOSICION MEZCLADA (PIB), PARA COINFECTAR INSECTOS HUESPEDES Y PARA PRODUCIR HETEROLOGAS EN INSECTOS. LOS PIB, CONTENIENDO UNA MEZCLA DE NUCLEOCAPSIDOS DE POR LO MENOS DOS BACULOVIRUS GENETICAMENTE DISTINTOS, SE OBTIENEN INFECTANDO UN CULTIVO CELULAR DE CELULAS QUE TOLERAN EL BACULOVIRUS CON LA FORMA NO OCLUIDA DE LOS BACULOVIRUS GENETICAMENTE DISTINTOS Y CULTIVANDO LAS CELULAS INFECTADAS, O BIEN INFECTANDO UN INSECTO CON LOS BACULOVIRUS GENETICAMENTE DISTINTOS. LA COINFECCION DEL INSECTO HUESPED SE EFECTUA PERMITIENDO QUE EL INSECTO INGIERA UNA CANTIDAD EFICAZ DEL PIB LO QUE ORIGINA UNA INFECCION VIRICA MIXTA EN EL MISMO. DESARROLLANDO EL INSECTO O CELULAS EN CONDICIONES ADECUADAS QUE PERMITAN LA REPLICACION VIRICA, SE CONSIGUE LA PRODUCCION DE PROTEINAS HETEROLOGAS CODIFICADAS POR EL GEN HETEROLOGO PRESENTE EN UNO DE LOS BACULOVIRUS. APLICACION EN INGENIERIA GENETICA PARA LA SINTESIS DE PROTEINAS HETEROLOGAS EN CELULAS DE INSECTOS.
ES878702586A 1986-09-09 1987-09-08 Metodos para producir cuerpos de inclusion polihedrica de composicion mezclada (pib),para coinfectar insectos huespedes y para producir proteinas heterologas en insectos. Expired ES2008204A6 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US90572986A 1986-09-09 1986-09-09

Publications (1)

Publication Number Publication Date
ES2008204A6 true ES2008204A6 (es) 1989-07-16

Family

ID=25421367

Family Applications (1)

Application Number Title Priority Date Filing Date
ES878702586A Expired ES2008204A6 (es) 1986-09-09 1987-09-08 Metodos para producir cuerpos de inclusion polihedrica de composicion mezclada (pib),para coinfectar insectos huespedes y para producir proteinas heterologas en insectos.

Country Status (8)

Country Link
EP (1) EP0323974B1 (es)
JP (1) JPH02500402A (es)
AU (1) AU601232B2 (es)
CA (1) CA1330426C (es)
DE (1) DE3788352T2 (es)
ES (1) ES2008204A6 (es)
WO (1) WO1988002030A1 (es)
ZA (1) ZA876696B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8810808D0 (en) * 1988-05-06 1988-06-08 Wellcome Found Vectors
JP2511494B2 (ja) * 1988-05-12 1996-06-26 善治 松浦 日本脳炎ウイルス表面抗原蛋白質の製造法
WO1990001556A1 (en) * 1988-08-05 1990-02-22 Mount Sinai School Of Medicine Of The City University Of New York In vivo infection of live insects with a recombinant baculovirus
AU4647889A (en) * 1988-11-18 1990-06-12 Cetus Corporation Insect signal peptide mediated secretion of recombinant proteins
US5272063A (en) * 1988-11-22 1993-12-21 Syntex (U.S.A.) Inc. Process of making human nerve growth factor
US5145775A (en) * 1989-02-28 1992-09-08 Research Association For Biotechnology Of Agricultural Chemicals Polyhedrin gene and genetic engineering thereof
GB9219562D0 (en) 1992-03-11 1992-10-28 Prendergast Kennet F Anti-viral peptides
US6130074A (en) * 1992-06-01 2000-10-10 American Cyanamid Company Five Giralda Farms Recombinant insect virus with reduced capacity for host-to-host transmission in the environment and methods to produce said virus
HU218849B (hu) * 1992-06-01 2000-12-28 American Cyanamid Co. Gazdaszervezetről gazdaszervezetre a környezetben csökkent terjedési képességgel rendelkező rekombináns bakulovirus és eljárás előállítására
DE69632658T2 (de) * 1995-03-14 2005-06-09 Akzo Nobel N.V. Expression in der selben Zelle von Polypeptide vom schweinen reproduktiven und respiratorischen Syndrom
PL3049516T3 (pl) 2013-09-23 2019-02-28 Association Pour La Rech Et Le Developpement Des Methodes Et Processus Industriels Armines Wytwarzanie wirusowych ciałek okluzyjnych, które zamykają wiriony zawierające genomy z różnych gatunków bakulowirusów, które można stosować do zwalczania szkodników będących owadami

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK518384A (da) * 1984-01-31 1985-07-01 Idaho Res Found Vektor til fremstilling af et gen-produkt i insektceller, fremgangsmaade til dens fremstilling samt dens anvendelse
EP0222412B1 (en) * 1985-11-14 1992-11-19 Daiichi Pharmaceutical Co., Ltd. Method of producing peptides
NZ221702A (en) * 1986-09-08 1989-02-24 Bishop David H L Expression of human hepatitis b antigens in insects and cultured insect cells using recombinant baculoviruses

Also Published As

Publication number Publication date
EP0323974B1 (en) 1993-12-01
ZA876696B (en) 1988-05-25
AU601232B2 (en) 1990-09-06
DE3788352T2 (de) 1994-03-17
DE3788352D1 (de) 1994-01-13
JPH02500402A (ja) 1990-02-15
EP0323974A1 (en) 1989-07-19
AU8032387A (en) 1988-04-07
EP0323974A4 (en) 1990-02-21
WO1988002030A1 (en) 1988-03-24
CA1330426C (en) 1994-06-28

Similar Documents

Publication Publication Date Title
ES2008204A6 (es) Metodos para producir cuerpos de inclusion polihedrica de composicion mezclada (pib),para coinfectar insectos huespedes y para producir proteinas heterologas en insectos.
ES8600783A1 (es) Procedimiento para la preparacion de la hormona polipeptidica factor de crecimiento de nervios de humano.
DE68922917D1 (de) KEX2-Endoprotease und Verfahren zu ihrer Herstellung.
KR870700074A (ko) Fsh
AU5443890A (en) Improvements in or relating to enhancers
HK140195A (en) Hybrid particle immunogens
IE873213L (en) Galenical Formulation
AU4921590A (en) Pf 1022 substance, method of producing same and anthelmintic composition containing same
AU8607291A (en) Expression system
DE3586801D1 (de) Synthetische hepatitis-b-virus-vakzine die t-zellen- und b-zellenbestimmer enthalten.
EP0111389A3 (en) Substantially pure porcine growth hormone, dna sequences therefor, and expression vehicles and transfected microorganisms for the production of porcine growth hormone
CA2051375A1 (en) Process and compositions for the isolation of human relaxin
EP0272858A3 (en) Recombinant hiv envelope proteins produced in insect cells
HK140095A (en) Hepatitis surface antigen particle vaccine
CA2019803A1 (en) Feline interferon and process for production thereof
AU1090688A (en) Synthetic porcine growth hormone
Takano et al. Practical preparation of optically active O-benzylglycidol from optically active epichlorohydrin
EP0288198A3 (en) Production of peptide
IE871639L (en) Varicella-zoster virus.
ES449894A1 (es) Procedimiento para la produccion de una composicion insecti-cida viral.
JPS644239A (en) Glycol dispersion of calcium carbonate
ES8706204A1 (es) Procedimiento de preparacion de metoprolol y-o de eter 4-(2-metoxietil)-fenilglicidilico
JPS5722650A (en) Preparation of feed
AU3964085A (en) Novel expression plasmids containing the full cDNA sequence of calf prochymosin
EP0836484A4 (en) IN-VITRO PACKING OF ADENO-ASSOCIATED VIRUS DNA